BLEOMYCIN A-2 (118998)

Compound Details

NameBLEOMYCIN A-2
Compound class18022A5DDE1E7HFMM012753778599
Compound codePROTEID

Summary

Compound class: 18022A5DDE1E7HFMM012753778599

Experiments: 34

View Experiments

Experiments (34)

Filters
Worktypes (21)
14
10
5
5
3
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
No match
Pharmacology (11)
4
3
2
2
2
2
1
1
1
1
15
No match
Compounds (128)
34
6
3
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
No match
Organisms (28)
4
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
No match
34 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)
1000775
PHARMACOLOGY OF COMPOUND - IN VIVO
TOXICITY ASSESSMENT(QUANTITATIVE)
Empty organism
1003413
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA SYNTHESIS INHIBITION
Empty organism
590585
PARTIAL SYNTHESIS OF
Empty organism
328335
CHEMICAL CONVERSION OFIDENTIFICATION OFANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)TLC DATA REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
Streptosporangium violaceochromogenes (STREPTOSPORANGIACEAE)
983807
REVIEW OFMICROBIAL TRANSFORMATION OF
Empty organism
1001705
PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
TOXIC EFFECT(GENERAL)
Empty organism
1028315
COMPLETE SYNTHESIS REPORTED
Empty organism
1001540
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Empty organism
591472
PARTIAL SYNTHESIS OF
Empty organism
821327
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
996187
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATA REPORTEDISOLATION AND IDENTIFICATION OF
Streptomyces species (STREPTOMYCETACEAE)
1000776
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
1028665
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA DISRUPTION EFFECT
Empty organism
614610
ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)TLC DATA REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
Empty organism
1180727
PHARMACOLOGY OF COMPOUND - IN VITRO
REVERSE TRANSCRIPTASE INHIBITION
Empty organism
1006612
STRUCTURE DETERMINATION OFN-15 MAGNETIC SPECTRUM REPORTED FOR
Empty organism
1003414
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA SYNTHESIS INHIBITION
Empty organism
838826
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA SCISSION EFFECT
Empty organism
590584
PARTIAL SYNTHESIS OF
Empty organism
618580
STRUCTURE DETERMINATION OFCMR SPECTRUM REPORTEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
Empty organism
821328
PHARMACOLOGY OF COMPOUND - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
393955
COMPLETE SYNTHESIS REPORTED
Empty organism
994333
PHARMACOLOGY OF COMPOUND - IN VITROMECHANISM OF ACTION STUDIED
DNA DISRUPTION EFFECT
Empty organism
1000342
PHARMACOLOGY OF COMPOUND - IN VITRO
DOPAMINE BETA-HYDROXYLASE INHIBITION
Empty organism
1180728
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Empty organism
1021036
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA DISRUPTION EFFECT
Empty organism
821325
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CELL CYCLE CYTOTOXICITY(G2 PHASE)
Empty organism
1000208
ISOLATION AND IDENTIFICATION OF
Streptomyces verticillatus (STREPTOMYCETACEAE)
1000343
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA DISRUPTION EFFECT
Empty organism
1142348
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYHPLC SEPARATION DATA FOR
Empty organism
996304
PARTIAL SYNTHESIS OF
Empty organism
990296
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA SCISSION EFFECT
Empty organism
591471
PARTIAL SYNTHESIS OF
Empty organism
821326
PHARMACOLOGY OF COMPOUND - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGSANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CELL CYCLE CYTOTOXICITY(G2 PHASE)
Empty organism
Show SPARQL Queries (1)